Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001140361-22-019978

President and CEO sold 13,913 shares at $5.32 ($73,962)

From the SEC's structured data for this filing

Trades in this filing

Touchon Pascal · President and CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2022-05-17 Sale : show line 1 in the form −13,913 $5.32 $73,962 486,313 D
Open-market sales · 13,913 sh · avg $5.32 · $73,962
Loading xslF345X03/form4.xml…